Anti-Muscarinic Agents Alone and in Combination With a Muscarinic Agonist in Subjects with Overactive Bladder(OAB) Symptoms

Trial Profile

Anti-Muscarinic Agents Alone and in Combination With a Muscarinic Agonist in Subjects with Overactive Bladder(OAB) Symptoms

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Jul 2012

At a glance

  • Drugs Imidafenacin (Primary) ; Pilocarpine (Primary) ; Propiverine (Primary) ; Solifenacin (Primary)
  • Indications Overactive bladder
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Jul 2012 Actual end date (30 Jun 2012) added as reported by University Hospital Medical Information Network - Japan.
    • 20 Jul 2012 Actual initiation date (1 Feb 2012) added as reported by University Hospital Medical Information Network - Japan.
    • 30 Jun 2012 Status changed from not yet recruiting to completed as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top